SOCS1 prevents graft arteriosclerosis by preserving endothelial cell function

Journal of the American College of Cardiology

Volumn 63, Issue 1, 2014, Pages 21-29

  Qin, Lingfeng ^a,b   Huang, Qunhua ^a   Zhang, Haifeng ^a   Liu, Renjing ^a   Tellides, George ^a   Min, Wang ^a   Yu, Luyang ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

endothelial activation; endothelial adhesion molecule; SOCS1

Indexed keywords

CELL ADHESION MOLECULE; INTERCELLULAR ADHESION MOLECULE 1; SUPPRESSOR OF CYTOKINE SIGNALING 1; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CELL CULTURE; CELL FUNCTION; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; GRAFT ARTERIOSCLEROSIS; GRAFT FAILURE; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LEUKOCYTE ADHERENCE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; CARDIAC GRAFT REJECTION; CORRELATIONAL STUDY; DISEASE EXACERBATION; IN VITRO STUDY; LEUKOCYTE FUNCTION AND CHARACTERISTICS; LEUKOCYTE RECRUITMENT; NEOINTIMA; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EC; ENDOTHELIAL ACTIVATION; ENDOTHELIAL ADHESION MOLECULE; ENDOTHELIAL CELL; GA; GRAFT ARTERIOSCLEROSIS; ICAM; INTERCELLULAR ADHESION MOLECULE; JAK; JANUS KINASE; PECAM; PLATELET/ENDOTHELIAL CELL ADHESION MOLECULE; SIGNAL TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION; SOCS1; STAT; SUPPRESSOR OF CYTOKINE SIGNALING 1; VASCULAR CELL ADHESION MOLECULE; VCAM;

ANIMALS; ARTERIOSCLEROSIS; BLOTTING, WESTERN; CELLS, CULTURED; DISEASE MODELS, ANIMAL; DNA; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; GENE EXPRESSION REGULATION; GRAFT OCCLUSION, VASCULAR; HUMANS; MICE; MICE, TRANSGENIC; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84891784260     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.08.694     Document Type: Article

References (35)

1. P. Libby, and J.S. Pober Chronic rejection Immunity 14 2001 387 397
2. K. Lietz, and L.W. Miller Current understanding and management of allograft vasculopathy Semin Thorac Cardiovasc Surg 16 2004 386 394
3. T.A. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76 1994 301 314
4. A. Ryo, F. Suizu, and Y. Yoshida et al. Regulation of NF-kappaB signaling by Pin1-dependent prolyl isomerization and ubiquitin-mediated proteolysis of p65/RelA Mol Cell 12 2003 1413 1426
5. Y. He, W. Zhang, R. Zhang, H. Zhang, and W. Min SOCS1 inhibits tumor necrosis factor-induced activation of ASK1-JNK inflammatory signaling by mediating ASK1 degradation J Biol Chem 281 2006 5559 5566
6. L. Yu, W. Min, and Y. He et al. JAK2 and SHP2 reciprocally regulate tyrosine phosphorylation and stability of proapoptotic protein ASK1 J Biol Chem 284 2009 13481 13488
7. T. Naka, T. Matsumoto, and M. Narazaki et al. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice Proc Natl Acad Sci U S A 95 1998 15577 15582
8. R. Starr, D. Metcalf, and A.G. Elefanty et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1 Proc Natl Acad Sci U S A 95 1998 14395 14399
9. C.R. Yu, R.R. Mahdi, and H.M. Oh et al. Suppressor of cytokine signaling-1 (SOCS1) inhibits lymphocyte recruitment into the retina and protects SOCS1 transgenic rats and mice from ocular inflammation Invest Ophthalmol Vis Sci 52 2011 6978 6986
10. M. Solomon, M. Flodstrom-Tullberg, and N. Sarvetnick Differences in suppressor of cytokine signaling-1 (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice Transplantation 79 2005 1104 1109
11. R. Balabanov, K. Strand, A. Kemper, J.Y. Lee, and B. Popko Suppressor of cytokine signaling 1 expression protects oligodendrocytes from the deleterious effects of interferon-gamma J Neurosci 26 2006 5143 5152
12. P.J. Egan, K.E. Lawlor, W.S. Alexander, and I.P. Wicks Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation J Clin Invest 111 2003 915 924
13. M.M. Chong, Y. Chen, and R. Darwiche et al. Suppressor of cytokine signaling-1 overexpression protects pancreatic beta cells from CD8+ T cell-mediated autoimmune destruction J Immunol 172 2004 5714 5721
14. M. Flodstrom-Tullberg, D. Yadav, and R. Hagerkvist et al. Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse Diabetes 52 2003 2696 2700
15. J. Roman-Gomez, A. Jimenez-Velasco, and J.A. Castillejo et al. The suppressor of cytokine signaling-1 is constitutively expressed in chronic myeloid leukemia and correlates with poor cytogenetic response to interferon-alpha Haematologica 89 2004 42 48
16. W. Sasi, W.G. Jiang, A. Sharma, and K. Mokbel Higher expression levels of SOCS 1,3,4,7 are associated with earlier tumour stage and better clinical outcome in human breast cancer BMC Cancer 10 2010 178
17. A.A. Melnikov, D. Scholtens, M.S. Talamonti, D.J. Bentrem, and V.V. Levenson Methylation profile of circulating plasma DNA in patients with pancreatic cancer J Surg Oncol 99 2009 119 122
18. O. Galm, H. Yoshikawa, M. Esteller, R. Osieka, and J.G. Herman SOCS-1, a negative regulator of cytokine signaling, is frequently silenced by methylation in multiple myeloma Blood 101 2003 2784 2788
19. W. Min, and J.S. Pober AIP1 in graft arteriosclerosis Trends Cardiovasc Med 21 2011 229 233
20. L. Yu, L. Qin, and H. Zhang et al. AIP1 prevents graft arteriosclerosis by inhibiting IFN-γ-dependent smooth muscle cell proliferation and intimal expansion Circ Res 109 2011 418 427
21. R.N. Mitchell Allograft arteriopathy: pathogenesis update Cardiovasc Pathol 13 2004 33 40
22. J. Koulack, V.C. McAlister, M.A. MacAulay, H. Bitter-Suermann, A.S. MacDonald, and T.D. Lee Importance of minor histocompatibility antigens in the development of allograft arteriosclerosis Clin Immunol Immunopathol 80 1996 273 277
23. J.C. Marine, D.J. Topham, and C. McKay et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality Cell 98 1999 609 616
24. M. Boratynska, M. Klinger, P. Szyber, D. Patrzalek, and K. Polak Interleukin-6 in chronic renal allograft rejection: influence of nonimmunologic risk factors Transplant Proc 33 2001 1215 1217
25. M.C. Deng, G. Plenz, and C. Labarrere et al. The role of IL6 cytokines in acute cardiac allograft rejection Transplant Immunol 9 2002 115 120
26. G. Plenz, H. Eschert, and M. Erren et al. The interleukin-6/interleukin- 6-receptor system is activated in donor hearts J Am Coll Cardiol 39 2002 1508 1512
27. G. Tellides, and J.S. Pober Interferon-gamma axis in graft arteriosclerosis Circ Res 100 2007 622 632
28. G. Tellides, D.A. Tereb, and N.C. Kirkiles-Smith et al. Interferon-gamma elicits arteriosclerosis in the absence of leukocytes Nature 403 2000 207 211
29. J.L. Zehnder, K. Hirai, M. Shatsky, J.L. McGregor, L.J. Levitt, and L.L. Leung The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytes J Biol Chem 267 1992 5243 5249
30. W.A. Muller, and F.W. Luscinskas Assays of transendothelial migration in vitro Methods Enzymol 443 2008 155 176
31. H.F. Langer, and T. Chavakis Leukocyte-endothelial interactions in inflammation J Cell Mol Med 13 2009 1211 1220
32. K.A. Roebuck, and A. Finnegan Regulation of intercellular adhesion molecule-1 (CD54) gene expression J Leukoc Biol 66 1999 876 888
33. B. Saha, S. Jyothi Prasanna, B. Chandrasekar, and D. Nandi Gene modulation and immunoregulatory roles of interferon gamma Cytokine 50 2010 1 14
34. G.M. Davey, W.R. Heath, and R. Starr SOCS1: a potent and multifaceted regulator of cytokines and cell-mediated inflammation Tissue Antigens 67 2006 1 9
35. G. Ortiz-Munoz, J.L. Martin-Ventura, and P. Hernandez-Vargas et al. Suppressors of cytokine signaling modulate JAK/STAT-mediated cell responses during atherosclerosis Arterioscler Thromb Vasc Biol 29 2009 525 531